AC Immune SA

Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.

ACIU | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: EPFL INNOVATION PARK, BUILDING B, 0 1015 LAUSANNE
Website:: https://www.acimmune.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

AC Immune SA is a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases. The company focuses on developing innovative ways to diagnose, treat, and prevent conditions such as Alzheimer’s disease, Parkinson’s disease, and other rare neuro-orphan indications. Its broad and diversified pipeline is built on proprietary technology platforms and includes multiple treatment modalities, such as active immunotherapies, monoclonal antibodies, small molecule drugs, and diagnostic agents. These product candidates are designed to target and clear the pathological, misfolded proteins that are central to neurodegeneration. The company's scientific leadership and pipeline are validated through strategic collaborations with global pharmaceutical leaders.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AC Immune SA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AC Immune SA

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for AC Immune SA via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
AIM ImmunoTech Inc. Develops immuno-therapeutics for cancers, immune disorders, and viral diseases.	United States of America	AIM
AKANDA CORP. Cultivates and distributes pharma-quality medical cannabis for patients in legal markets worldwide.	United States of America	AKAN
Akari Therapeutics Plc A clinical-stage oncology company developing next-gen ADCs for targeted cancer therapy.	United States of America	AKTX
Akebia Therapeutics, Inc. Developing and commercializing novel, FDA-approved therapeutics for kidney disease.	United States of America	AKBA
Akero Therapeutics, Inc. A clinical-stage biotech developing therapies for serious metabolic diseases like MASH.	United States of America	AKRO
Alaunos Therapeutics, Inc. Developing TCR-T cell therapies to treat solid tumors by targeting specific cancer mutations.	United States of America	TCRT
Aldeyra Therapeutics, Inc. Biotech developing therapies for ocular and systemic immune-mediated inflammation.	United States of America	ALDX
Alector, Inc. Pioneers immuno-neurology therapies for neurodegenerative diseases like Alzheimer's.	United States of America	ALEC
Aligos Therapeutics, Inc. Clinical-stage biopharma developing novel oral therapies for liver and viral diseases.	United States of America	ALGS
ALK-Abelló Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.	Denmark	ALK